Myocardial Ischemia, Angina Pectoris: Clinical Trials

1 trial for Myocardial Ischemia, Angina Pectoris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Myocardial Ischemia, Angina Pectoris: new trials by email Literature Review of Myocardial Ischemia, Angina Pectoris trials Research Report on Myocardial Ischemia, Angina Pectoris

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure
Intramyocardial injection of autologous CD133+ marrow cells - Coronary Artery Disease With Need for Bypass Surgery, Myocardial Ischemia, Angina Pectoris
Phase 2 / Phase 3CompletedGerman Heart Institute602007-04-012013-01-16

Narrower conditions

Angina Pectoris (1)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Chest Pain (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Necrosis (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Sponsors

German Heart Institute (1)

Countries

Germany (1)

Top investigators

Boris Nasseri, MD (1)  ·  Christof Stamm, MD (1)  ·  Roland Hetzer, MD, PhD (1)

Results publications

PMID 24497345